ESWI Education Hub provides articles and links to important scientific papers, reviewed by the ESWI Board members, and other online educational activities

Filters
  • Risk group: Older adults
🔍Topics
🔍Medium
🔍Risk groups
🔍Networks
  1. News
    Podcast Series: hMPV – A Common Yet Unknown Respiratory Threat
    In this 3-part podcast series, the International Federation on Ageing (IFA) aims to raise awareness of hMPV. The series will feature scientists, clinicians and the voices of older people and groups representing those most at risk of serious disease.
    Read more
  2. News,Scientific Papers
    Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults
    Older adults, especially those over 65 years of age, face increased risks of immune senescence, chronic comorbidities, and decreased vaccine efficacy.
    Read more
  3. Scientific Papers,News
    The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
    This Review provides an overview of RSV vaccines highlighting different target populations, antigens, and trial results. As RSV vaccines have not yet reached low-income and middle-income countries, next steps are outlined to minimise the delay.
    Read more
  4. Video,FAQ
    What are the risks of RSV infections for older individuals?
    ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
    Read more
  5. Article,Scientific Papers
    Age, comorbidity burden and late presentation are significant predictors of hospitalization length and acute respiratory failure in patients with influenza
    Influenza viruses are responsible for a high number of infections and hospitalizations every year.
    Read more
  6. Scientific Papers,News
    Respiratory Syncytial Virus Infection in Older Adults: An Update
    Respiratory syncytial virus (RSV) infection represents one of the most common infections during childhood, with significant morbidity and mortality in newborns and in the early years of life.
    Read more
  7. News,Scientific Papers
    How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?
    Respiratory syncytial virus (RSV) and influenza infections cause significant annual morbidity and mortality worldwide in at-risk populations.
    Read more
  8. News,Infographic
    General Practice Survey
    The Immunisation Coalition asked 19 questions, all related to vaccination.
    Read more
  9. Scientific Papers,News
    Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
    Respiratory syncytial virus (RSV) infection can cause severe respiratory illness in older adults.
    Read more
  10. News,Scientific Papers
    Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
    It is well-established that older adults are at increased risk of severe and fatal COVID-19, but the mechanisms underlying this susceptibility are not entirely clear.
    Read more
  11. Scientific Papers,News
    The influenza landscape and vaccination coverage in older adults during theSARS-Cov-2 pandemic: data from Several European Countries and Israel
    While influenza and the common cold are both contagious viral respiratory tract illnesses, influenza can be a serious disease that could lead to severe complications and unfavorable outcomes due to broader consequences.
    Read more
  12. Video
    ESWI Summit 2024: Conclusions
    Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024
    Read more
  13. Video
    ESWI Summit 2024: Science Policy Interface debate
    How to ensure/prepare for access to immunisation programmes
    Read more
  14. Video
    ESWI Summit 2024: Rapporteur from the RSVVW’ 2024 meeting in Mumbai
    By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024
    Read more
  15. Video
    ESWI Summit 2024: What's in the pipeline?
    Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics
    Read more
  16. Video
    ESWI Summit 2024: Early Career Scientists
    ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.
    Read more
  17. Video
    ESWI Summit 2024: Diagnostics and Point of Care Testing
    Keynote Lecture by Dexter Wiseman, Imperial College London
    Read more
  18. Video
    ESWI Summit 2024: Burden of disease in older adults
    Keynote Lecture by Stefan Gravenstein, Brown University
    Read more
  19. Video
    ESWI Summit 2024: Burden of disease in infants
    Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust
    Read more
  20. Scientific Papers,Article
    Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Disea
    Influenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions.
    Read more